Location History:
- München, DE (2001)
- Munich, DE (2003 - 2006)
- Frankfurt-am-Main, DE (2010)
Company Filing History:
3 out of 1,678 
2 out of 57 Years Active: 2001-2010
Title: Innovations and Contributions of Harald Trauthwein
Introduction
Harald Trauthwein is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of novel polypeptides and catalytic reactions. With a total of five patents to his name, Trauthwein's work has implications for the pharmaceutical industry and beyond.
Latest Patents
One of Trauthwein's latest patents focuses on alcohol dehydrogenases. This invention relates to novel polypeptides that exhibit the biological activity of NAD- or NADP-dependent alcohol dehydrogenases. The invention also encompasses nucleic acids encoding these polypeptides, nonhuman hosts or host cells, and reaction systems for preparing desired products. The polypeptides are particularly useful in synthesizing primary and enantiomerically pure secondary alcohols, which can serve as intermediates for medicaments. Additionally, these polypeptides can be utilized in the reverse reaction, facilitating the oxidation of alcohols to form aldehydes or ketones. Another significant patent involves chiral ligands and their catalytic applications. This invention introduces novel chiral ligands and outlines their production and use in various catalytic reactions.
Career Highlights
Throughout his career, Trauthwein has worked with prominent companies such as Degussa Aktiengesellschaft and Aventis Research & Technologies GmbH & Co. KG. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in his field.
Collaborations
Trauthwein has collaborated with esteemed colleagues, including Thomas Riermeier and Matthias Beller. These partnerships have further enhanced his research and innovation capabilities.
Conclusion
Harald Trauthwein's contributions to biochemistry through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of new pharmaceutical intermediates and catalytic processes.